Abbott India Limited has been served with a GST penalty order amounting to ₹2.40 crore by the Office of the Principal Commissioner of CGST and Central Excise, Mumbai East Commissionerate. The company received the order on December 30, 2025.
The demand pertains to multiple financial years 2018-19, 2019-20, 2021-22 and 2023-24 and arises from the disallowance of Input Tax Credit (ITC) by the GST authorities following assessment proceedings carried out by the Mumbai East jurisdiction.
In compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Abbott India disclosed the development to stock exchanges as part of its obligation to keep investors informed of material regulatory actions.
The order alleges violations related to the availing of ITC. However, Abbott India has categorically stated that it disagrees with the conclusions reached by the tax authorities and maintains that the demand raised is not sustainable under prevailing law.
The company also clarified that the penalty will not have any material impact on its financial condition, operational performance, or business continuity. It has initiated steps to challenge the order and plans to file an appeal before the appropriate appellate authority.
Expressing confidence in its legal position, Abbott India said it expects a favourable outcome through the appellate process. The disclosure was filed with BSE Limited and signed by Company Secretary Sangeeta Shetty.
Headquartered at Godrej BKC in Mumbai’s Bandra-Kurla Complex, Abbott India reaffirmed its commitment to regulatory compliance and assured stakeholders that the matter will not affect its ongoing operations or financial stability.
